AirSculpt Technologies, Inc.
AIRSAirSculpt Technologies is a specialized medical aesthetics provider that offers proprietary, minimally invasive body contouring and fat transfer procedures.
Earnings
Next report
Nov 9, 2026 (In 3 weeks)Financials
Q2 2026Valuation & ratios
Segments
By segment
Competitors
By market cap
By revenue growth
By net margin
Profile
AirSculpt Technologies is a specialized medical aesthetics provider that offers proprietary, minimally invasive body contouring and fat transfer procedures. The company operates a network of luxury, spa-like centers across North America, utilizing a patented method that eliminates the need for needles, scalpels, or general anesthesia. Its core value proposition centers on providing precise, permanent fat removal and skin tightening with significantly reduced recovery times compared to traditional surgical alternatives.
A premium, branded provider of proprietary minimally invasive alternatives to traditional liposuction and non-surgical fat reduction.
FAQ
- What is AirSculpt Technologies, Inc.'s market cap?
- AirSculpt Technologies, Inc. (AIRS) has a market capitalization of $116.8M and trades on NASDAQ.
- What is AirSculpt Technologies, Inc.'s revenue and profitability?
- AirSculpt Technologies, Inc. generated $150.7M in trailing twelve-month revenue with a net loss of $13.6M, representing a net margin of -11.3%. Gross margin stands at 59.7%. The latest reported period is Q2 2026.
- Who are AirSculpt Technologies, Inc.'s competitors?
- AirSculpt Technologies, Inc.'s key competitors include AbbVie Inc., InMode Ltd., Eli Lilly and Company, and others. These companies compete in similar markets and product categories.
- Where is AirSculpt Technologies, Inc. headquartered?
- AirSculpt Technologies, Inc. is headquartered in United States of America and employs approximately 381 people. It has been publicly traded since 2021.
